FESTSCHRIFT - Fachklinik-Hornheide

7 LITER ATUR
system blockade on cardiac monophasic
action potentials and effective refractoriness
in awake dogs. Anesthesiology 2001;95:132-
8; discussion 6A.
35. Blomberg S, Curelaru I, Emanuelsson H,
Herlitz J, Ponten J, Ricksten SE. Thoracic
epidural anaesthesia in patients with unstable
angina pectoris. Eur Heart J 1989;10:437-44.
36. Blomberg S, Emanuelsson H, Kvist H,
Lamm C, Ponten J, waagstein F, Ricksten
SE. Effect of thoracic epidural anesthesia on
coronary arteries and arterioles in patients
coronary artery diesease. Anesthesiology
1990;73:840-7.
37. Nygard E, Kofoed KF, Freiberg J, Holm S,
Aldershvile J, Eliasen K, Kelbaek H. Effects
of high thoracic epidural analgesia on myocardial
blood flow in patients with ischemic
heart disease. Circulation 2005;111:2165-70.
38. Liu SS, Block BM, Wu CL. Effects of perioperative
central neuraxial analgesia on outcome
after coronary artery bypass surgery: a metaanalysis.
Anesthesiology 2004;101:153-61.
39. Nishimori M, Ballantyne JC, Low JH.
Epidural pain relief versus systemic opioidbased
pain relief for abdominal aortic surgery.
Cochrane Database Syst Rev 2006;3:
CD005059.
40. Beattie WS, Badner NH, Choi P. Epidural
analgesia reduces postoperative myocardial
infarction: a meta-analysis. Anesth Analg
2001;93:853-8.
41. Beattie WS, Badner NH, Choi PT. Meta-analysis
demonstrates statistically significant reduction
in postoperative myocardial infarction
with the use of thoracic epidural analgesia.
Anesth Analg 2003;97:919-20.
42. Singh N, Sidawy AN, Dezee K, Neville RF,
Weiswasser J, Arora S, Aidinian G, Abularrage
C, Adams E, Khuri S, Henderson
WG. The effects of the type of anesthesia
on outcomes of lower extremity infrainguinal
bypass. J Vasc Surg 2006;44:964-8; discussion
8-70.
43. Parker MJ, Handoll HH, Griffiths R.
Anaesthesia for hip fracture surgery in
adults. Cochrane Database Syst Rev 2001:
CD000521.
44. Parker MJ, Handoll HH, Griffiths R.
Anaesthesia for hip fracture surgery in
adults. Cochrane Database Syst Rev 2004:
CD000521.
45. Ballantyne JC, Carr DB, deFerranti S,
Suarez T, Lau J, Chalmers TC, Angelillo
IF, Mosteller F. The comparative effects of
postoperative analgesic therapies on pulmonary
outcome: cumulative meta-analyses of
randomized, controlled trials. Anesth Analg
1998;86:598-612.
46. Jorgensen H, Wetterslev J, Moiniche S,
Dahl JB. Epidural local anaesthetics versus
opioid-based analgesic regimens on postoperative
gastrointestinal paralysis, PONV
and pain after abdominal surgery. Cochrane
Database Syst Rev 2000:CD001893.
47. Kehlet H. Manipulation of the metabolic
response in clinical practice. World J Surg
2000;24:690-5.
48. Beilin B, Shavit Y, Trabekin E, Mordashev
B, Mayburd E, Zeidel A, Bessler H. The
effects of postoperative pain management on
immune response to surgery. Anesth Analg
2003;97:822-7.
49. Brodner G, Pogatzki E, Buerkle H, Marcus
AE, van Aken H. Thoracic epidural analgesia
with ropivacaine attenuates postoperative immunesuppression.
Anesthesiology 1998;89:
A1168.
50. Elenkov IJ, Wilder RL, Chrousos GP, Vizi
ES. The sympathetic nerve--an integrative
interface between two supersystems: the
brain and the immune system. Pharmacol
Rev 2000;52:595-638.
51. Wiebalck A, Vandermeersch E, Van Aken
H. Postoperative patient-controlled epidural
analgesia (PCEA): Effects of the addition of
sufentanil in the elderly patient. Anesthesiology
1995;in press:0.
52. Hofer S, Högström H. The role of the nurse
in post-operative pain therapy. In: Breivik H,
ed. post-operative pain management. 0 ed.
London Philadelphia Sydney Tokyo Toronto:
Balliere Tindall, 1995:461-8.
53. Rawal N, Berggren L. Organization of
acute pain services: a low-cost model. Pain
1994;57:117-23.
54. Brodner G, Pogatzki E, Van Aken H. [A modern
concept of postoperative pain therapy].
Anaesthesist 1997;46 Suppl 2:S124-31.
55. Lehmann KA. Analgetika mit antipyretischer
Wirkung: Klinische Erfahrungen. In: Lehmann
KA, ed. Der postoperative Schmerz. 2 ed.
Berlin Heidelberg New York London Paris
Tokyo Hong Kong Barcelona Budapest:
Springer, 1995:167-83.
56. Dahl JB, Kehlet H. Non-steroidal anti-inflammatory
drugs: rationale for use in severe
postoperative pain. Br J Anaesth. 1991;66:
703-12.
57. Vane JR, Botting RM. The mechanism of action
of aspirin. Thromb Res 2003;110:255-8.
58. Chandrasekharan NV, Dai H, Roos KL,
Evanson NK, Tomsik J, Elton TS, Simmons
DL. COX-3, a cyclooxygenase-1 variant inhibited
by acetaminophen and other analgesic/
antipyretic drugs: cloning, structure, and expression.
Proc Natl Acad Sci U S A 2002;99:
13926-31.
59. Warner TD, Mitchell JA. Cyclooxygenase-3
(COX-3): filling in the gaps toward a COX continuum
Proc Natl Acad Sci U S A 2002;99:
13371-3.
60. Tacconelli S, Capone ML, Patrignani P. Clinical
pharmacology of novel selective COX-2
inhibitors. Curr Pharm Des 2004;10:589-601.
61. Shoor S. Athletes, nonsteroidal anti-inflammatory
drugs, coxibs, and the gastrointestinal
tract. Curr Sports Med Rep 2002;1:107-15.
62. Spiegel BM, Targownik L, Dulai GS,
Gralnek IM. The cost-effectiveness of cyclooxygenase-2
selective inhibitors in the
management of chronic arthritis. Ann Intern
Med 2003;138:795-806.
63. Aringer M. [Cyclooxygenase 2 selective
antirheumatic analgesics]. Wien Med Wochenschr
2003;153:100-3.
64. Patrignani P, Capone ML, Tacconelli S.
Clinical pharmacology of etoricoxib: a novel
selective COX2 inhibitor. Expert Opin Pharmacother
2003;4:265-84.
65. Hur C, Simon LS, Gazelle GS. The costeffectiveness
of aspirin versus cyclooxygenase-2-selective
inhibitors for colorectal
carcinoma chemoprevention in healthy
individuals. Cancer 2004;101:189-97.
66. Hur C, Simon LS, Gazelle GS. Analysis of
aspirin-associated risks in healthy individuals.
Ann Pharmacother 2005;39:51-7.
67. Psaty BM, Weiss NS. NSAID trials and the
choice of comparators--questions of public
health importance. N Engl J Med 2007;356:
328-30.
68. Kehlet H, Werner MU. [Role of paracetamol
in the acute pain management]. Drugs
2003;63 Spec No 2:15-22.
69. Pogatzki-Zahn EM, Zahn PK. [Systemic analgesia:
an update]. Anasthesiol Intensivmed
Notfallmed Schmerzther 2007;42:22-31.
70. Lehmann KA. Patient-controlled analgesia:
An efficient therapeutic tool in the postoperative
setting. Eur Surg Res 1999;31:112-21.
71. Wiebalck A, Vandermeulen E, Van Aken
H, Vandermeersch E. Konzept zur Verbesserung
der postoperativen Schmerzbehandlung.
Anaesthesist 1995;44:831-42.
72. Brodner G, Pogatzki E, Wempe H, Van
Aken H. Patientenkontrollierte postoperative
Epiduralanalgesie. Prospektive Pefunde von
1799 Patienten. Anaesthesist 1997;46 Suppl
3:S165-S71.
73. Schug SA, Large RG. Economic considerations
in pain management. PharmacoEconomics
1993;3:260-7.
74. Rauck RL. Cost-effectivness and cost/ratio
of acute pain management. Reg Anesth
1996;21:139-43.
75. de Leon Casasola OA, Parker BM, Lema
MJ, Groth RI, Orsini Fuentes J. Epidural
analgesia versus intravenous patient-controlled
analgesia. Differences in the postoperative
course of cancer patients. Reg Anesth
1994;19:307-15.
76. Brodner G, Pogatzki E, Van Aken H, Buerkle
H, Goeters C, Schulzki C, Nottberg H, Mertes
N. A multimodal approach to control postoperative
pathophysiology and rehabilitation
in patients undergoing abdominothoracic
esophagectomy. Anesth Analg 1998;86:
228-34.
77. Tsui SL, Chan CS, Chan AS, Wong SJ, Lam
CS, Jones RD. Postoperative analgesia for
oesophageal surgery: a comparison of three
analgesic regimens. Anaesth Intensive Care
1991;19:329-37.
78. Watson A, Allen PR. Influence of thoracic epidural
analgesia on outcome after resection
for esophageal cancer. Surgery 1994;115:
429-32.
79. Smedstad KG, Beattie WS, Blair WS, Buckley
DN. Postoperative pain relief and hospital
stay after total esophagectomy. Clin J Pain
1992;8:149-53.
88 | Fachklinik Hornheide | 75 Jahre | FESTSCHRIF T |